A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide VaccineResearch Article Published on 2022-04-152024-09-04 Journal: Movement Disorders [Category] 대상포진, [키워드] active immunotherapy first‐in‐human Parkinson's Disease Vaccine α‐synuclein [DOI] 10.1002/mds.29016 PMC 바로가기 [Article Type] Research Article